| Ytd | -42.43% | |
| 1y | -71.79% |
| Open | 0.37 | Prev Close | 0.38 | Low | 0.37 | High | 0.43 | Mkt Cap | 7.31M |
| Vol | 509.85K | Avg Vol | 1.24M | EPS | -1.27 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | 0.21 | Inst. Own | 4.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.39 | 200-d Avg | 0.92 | 1yr Est | 0.00 |
Mangoceuticals (NASDAQ:MGRX) reported quarterly losses of $(0.13) per share. This is a 87.13 percent
Mangoceuticals stock jumps despite no fresh news, as lawsuit dispute, TRT sales surge, and platform
Dow Jones rises over 800 points on Monday as U.S. stocks trade higher. NASDAQ and S&P 500 also s
Faraday Future Intelligent Electric shares up 54.8% in pre-market trading after SEC investigation en
Mangoceuticals, Inc. (NASDAQ:MGRX), a company focused on developing, marketing, and selling a variet
Mangoceuticals, Inc. (NASDAQ:MGRX), a company focused on developing, marketing, and selling a variet
Shares of Mangoceuticals are trading sharply higher Friday afternoon after the company reported mome
Mangoceuticals shares are trading higher Friday after the company announced initial success with its
Mangoceuticals, Inc. (NASDAQ:MGRX) (the "Company"), a company focused on developing, marketi
Novo Nordisk faces board changes, investor friction and bold M&A moves as leadership pushes to r
CSCO: 8% | Cisco shares are trading higher after the company reported strong Q1 earnings and issued
https://tsdr.uspto.gov/#caseNumber=99483190&caseSearchType=US_APPLICATION&caseType=DEFAULT&a
Mangoceuticals (NASDAQ:MGRX) reported quarterly losses of $(0.57) per share. This is a 57.78 percent
Mangoceuticals, Inc. (NASDAQ:MGRX) ("Mangoceuticals" or the "Company"), a company fo
Mangoceuticals, Inc. (NASDAQ:MGRX), a company focused on developing, marketing, and selling a variet
Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused o
Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused o
MangoRx strongly refutes any and all claims made by Eli Lilly regarding the sale of compounded tirze
Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session f
Gainers
Gainers
Gainers Nxu, Inc. (NASDAQ: NXU) shares surged 56.4% to $0.1079 in pre-market trading. On Oct. 17,